University Hospitals in Cleveland, Ohio is the latest facility to participate in novel clinical trials to combat COVID-19. The site will begin by testing an experimental monoclonal antibody treatment called LY-CoV555. To participate, enrollees must have tested positive for SARS-CoV-2 infection within seven days and started experiencing symptoms within ten days of enrolling in the study, though not requiring hospitalization. Regardless of how experimental and valuable the clinical trial substance, Yourway’s expansive transportation fleet, global regulatory expertise and dedicated project managers, make us the only truly integrated provider able to serve the full breadth of your drug product distribution needs.